Oligonucleotide-containing microspheres, their use for the manufacture of a medicament for treating diabetes type 1
AS-oligonucleotides are delivered in microsphere form in order to induce dendritic cell tolerance, particularly in the non-obese-diabetic (NOD) mouse model. The microspheres incorporate antisense (AS) oligonucleotides. A process includes using an antisense approach to prevent an autoimmune diabetes...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | TERRENCE L. SCOTT LARRY L. BROWN NICK GIANNOUKAKIS DEBORAH LAFRENIERE JENNIFER MACHEN VERED BISKER-LIEB |
| description | AS-oligonucleotides are delivered in microsphere form in order to induce dendritic cell tolerance, particularly in the non-obese-diabetic (NOD) mouse model. The microspheres incorporate antisense (AS) oligonucleotides. A process includes using an antisense approach to prevent an autoimmune diabetes condition in NOD mice in vivo and in situ. The oligonucleotides are targeted to bind to primary transcripts CD40, CD80, CD86 and their combinations. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2005244851A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2005244851A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2005244851A13</originalsourceid><addsrcrecordid>eNqNjL0KwkAQBtNYiPoOC7YGkpiAbRDFzkbrsF6-JAe5H-72Ct9egj6A1TAwzDqL91mPziY1w4nukStnhbXVdiSjVXDRTwiIB5IJOlCKoMGFxciwTQMrSQHkBmIy6LViAyvfJoBlGfWaXxBEkrcHldtsNfAcsftxk-2vl8f5lsO7DtGzgoV07bMqiqaq61NTtuXxv-oDiQ5FVw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Oligonucleotide-containing microspheres, their use for the manufacture of a medicament for treating diabetes type 1</title><source>esp@cenet</source><creator>TERRENCE L. SCOTT ; LARRY L. BROWN ; NICK GIANNOUKAKIS ; DEBORAH LAFRENIERE ; JENNIFER MACHEN ; VERED BISKER-LIEB</creator><creatorcontrib>TERRENCE L. SCOTT ; LARRY L. BROWN ; NICK GIANNOUKAKIS ; DEBORAH LAFRENIERE ; JENNIFER MACHEN ; VERED BISKER-LIEB</creatorcontrib><description>AS-oligonucleotides are delivered in microsphere form in order to induce dendritic cell tolerance, particularly in the non-obese-diabetic (NOD) mouse model. The microspheres incorporate antisense (AS) oligonucleotides. A process includes using an antisense approach to prevent an autoimmune diabetes condition in NOD mice in vivo and in situ. The oligonucleotides are targeted to bind to primary transcripts CD40, CD80, CD86 and their combinations.</description><language>eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2005</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20051201&DB=EPODOC&CC=AU&NR=2005244851A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20051201&DB=EPODOC&CC=AU&NR=2005244851A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>TERRENCE L. SCOTT</creatorcontrib><creatorcontrib>LARRY L. BROWN</creatorcontrib><creatorcontrib>NICK GIANNOUKAKIS</creatorcontrib><creatorcontrib>DEBORAH LAFRENIERE</creatorcontrib><creatorcontrib>JENNIFER MACHEN</creatorcontrib><creatorcontrib>VERED BISKER-LIEB</creatorcontrib><title>Oligonucleotide-containing microspheres, their use for the manufacture of a medicament for treating diabetes type 1</title><description>AS-oligonucleotides are delivered in microsphere form in order to induce dendritic cell tolerance, particularly in the non-obese-diabetic (NOD) mouse model. The microspheres incorporate antisense (AS) oligonucleotides. A process includes using an antisense approach to prevent an autoimmune diabetes condition in NOD mice in vivo and in situ. The oligonucleotides are targeted to bind to primary transcripts CD40, CD80, CD86 and their combinations.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2005</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjL0KwkAQBtNYiPoOC7YGkpiAbRDFzkbrsF6-JAe5H-72Ct9egj6A1TAwzDqL91mPziY1w4nukStnhbXVdiSjVXDRTwiIB5IJOlCKoMGFxciwTQMrSQHkBmIy6LViAyvfJoBlGfWaXxBEkrcHldtsNfAcsftxk-2vl8f5lsO7DtGzgoV07bMqiqaq61NTtuXxv-oDiQ5FVw</recordid><startdate>20051201</startdate><enddate>20051201</enddate><creator>TERRENCE L. SCOTT</creator><creator>LARRY L. BROWN</creator><creator>NICK GIANNOUKAKIS</creator><creator>DEBORAH LAFRENIERE</creator><creator>JENNIFER MACHEN</creator><creator>VERED BISKER-LIEB</creator><scope>EVB</scope></search><sort><creationdate>20051201</creationdate><title>Oligonucleotide-containing microspheres, their use for the manufacture of a medicament for treating diabetes type 1</title><author>TERRENCE L. SCOTT ; LARRY L. BROWN ; NICK GIANNOUKAKIS ; DEBORAH LAFRENIERE ; JENNIFER MACHEN ; VERED BISKER-LIEB</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2005244851A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2005</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>TERRENCE L. SCOTT</creatorcontrib><creatorcontrib>LARRY L. BROWN</creatorcontrib><creatorcontrib>NICK GIANNOUKAKIS</creatorcontrib><creatorcontrib>DEBORAH LAFRENIERE</creatorcontrib><creatorcontrib>JENNIFER MACHEN</creatorcontrib><creatorcontrib>VERED BISKER-LIEB</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>TERRENCE L. SCOTT</au><au>LARRY L. BROWN</au><au>NICK GIANNOUKAKIS</au><au>DEBORAH LAFRENIERE</au><au>JENNIFER MACHEN</au><au>VERED BISKER-LIEB</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Oligonucleotide-containing microspheres, their use for the manufacture of a medicament for treating diabetes type 1</title><date>2005-12-01</date><risdate>2005</risdate><abstract>AS-oligonucleotides are delivered in microsphere form in order to induce dendritic cell tolerance, particularly in the non-obese-diabetic (NOD) mouse model. The microspheres incorporate antisense (AS) oligonucleotides. A process includes using an antisense approach to prevent an autoimmune diabetes condition in NOD mice in vivo and in situ. The oligonucleotides are targeted to bind to primary transcripts CD40, CD80, CD86 and their combinations.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_AU2005244851A1 |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE |
| title | Oligonucleotide-containing microspheres, their use for the manufacture of a medicament for treating diabetes type 1 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T08%3A19%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=TERRENCE%20L.%20SCOTT&rft.date=2005-12-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2005244851A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |